Found 20 matching trials
Surfactant Versus Nasal Continuous Positive Airway Pressure (nCPAP) for Respiratory Distress Syndrome in the Newborn ≥ 35 Weeks of Gestation
PHASE3Term and near term newborns can present acute respiratory distress syndrome...
Location
Amiens University Hospital
OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP
PHASE4Trial question: Does administration of exogenous surfactant using a minimal...
Location
Yale-New Haven Children's Hospital
Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
PHASE2A Pilot study to evaluate the safety and the efficacy of endotracheal insti...
Location
NICU-Pitt County Memorial Hospital
Intra-tracheal Instillation of Budesonide to Prevent Chronic Lung Disease
PHASE4Preterm infants are randomized to received either Intra-tracheal instillati...
Location
University of Arizona
Prophylactic Minimally Invasive Surfactant Evaluation
PHASE4The purpose of this study is to explore the question: Does prophylactic adm...
Location
Northshore University Healthsystem
Administration of Surfactant Through an Instillation Device Infasurf® (Calfactant) in Neonates- A Pilot Study
PHASE2A pilot study to explore and determine feasibility and safety of the admini...
Location
Sharp Mary Birch Hospital for Women & Newborns
SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
PHASE2SURFAXIN® (lucinactant) treatment will be examined in very low birth weight...
Location
Discovery Laboratories, Inc.
ECALMIST Versus InSurE in Preterm Infant < 32 Weeks,Multicenter, Multinational RCT
NAMinimally invasive surfactant therapy via a small vascular catheter - ECALM...
Location
Health sciences Center
Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
PHASE2Treatment with lucinactant, a peptide-containing synthetic lung surfactant,...
Location
Call for information
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
PHASE1This study will evaluate the safety and efficacy of intravesical administra...
Location
The University of Alabama at Birmingham Clinical Research Unit (CRU)